Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter R Mansfield

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Psychotherapy and Psychosomatics|December 11, 2003
Escitalopram: superior to citalopram or a chiral chimera?Staffan Svensson, Peter R Mansfield
Journal of Epidemiology and Community Health|September 15, 2009
Physicians, the industry and population healthJuan Gérvas, Peter R Mansfield
Pharmacoepidemiology and Drug Safety|September 24, 2004
Misleading drug promotion--no sign of improvementsPeter R Mansfield, David Henry
International Journal of Health Services : Planning, Administration, Evaluation|December 13, 2007
Is Australia's national medicines policy failing? The case of COX-2 inhibitorsAgnes Vitry, Joel Lexchin, Peter R Mansfield
Australian Family Physician|June 3, 2005
Management of hyperlipidaemiaNigel Stocks, James Allan, Peter R Mansfield
BMJ (Clinical Research Ed.)|April 22, 2006
Blanket hepatitis B vaccination is questionable in IndiaPeter R Mansfield, Anant Phadke, Ashok Kale
The Medical Journal of Australia|October 27, 2005
Depressed youth, suicidality and antidepressantsPeter R Mansfield, Melissa K Raven, Jon N Jureidini
The Medical Journal of Australia|February 22, 2005
Withdraw all COX-2-selective drugsPeter R Mansfield, Agnés I Vitry, James M Wright
BMJ (Clinical Research Ed.)|January 1, 2005
Direct to consumer advertisingPeter R Mansfield, Barbara Mintzes, Dee Richards, et al.
Lancet (London, England)|March 19, 2003
Drug advertising in medical journalsPeter R Mansfield, Joel Lexchin, Agnés Vitry, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Psychotherapy and Psychosomatics|December 11, 2003
Escitalopram: superior to citalopram or a chiral chimera?Staffan Svensson, Peter R Mansfield
Journal of Epidemiology and Community Health|September 15, 2009
Physicians, the industry and population healthJuan Gérvas, Peter R Mansfield
Pharmacoepidemiology and Drug Safety|September 24, 2004
Misleading drug promotion--no sign of improvementsPeter R Mansfield, David Henry
International Journal of Health Services : Planning, Administration, Evaluation|December 13, 2007
Is Australia's national medicines policy failing? The case of COX-2 inhibitorsAgnes Vitry, Joel Lexchin, Peter R Mansfield
Australian Family Physician|June 3, 2005
Management of hyperlipidaemiaNigel Stocks, James Allan, Peter R Mansfield
BMJ (Clinical Research Ed.)|April 22, 2006
Blanket hepatitis B vaccination is questionable in IndiaPeter R Mansfield, Anant Phadke, Ashok Kale
The Medical Journal of Australia|October 27, 2005
Depressed youth, suicidality and antidepressantsPeter R Mansfield, Melissa K Raven, Jon N Jureidini
The Medical Journal of Australia|February 22, 2005
Withdraw all COX-2-selective drugsPeter R Mansfield, Agnés I Vitry, James M Wright
BMJ (Clinical Research Ed.)|January 1, 2005
Direct to consumer advertisingPeter R Mansfield, Barbara Mintzes, Dee Richards, et al.
Lancet (London, England)|March 19, 2003
Drug advertising in medical journalsPeter R Mansfield, Joel Lexchin, Agnés Vitry, et al.
Pageof 3